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Maturation of cytochrome oxidases is a complex process requiring
assembly of several subunits and adequate uptake of the metal
cofactors. Two orthologous Sco proteins (Sco1 and Sco2) are essential
for the correct assembly of the dicopper CuA site in the human
oxidase, but their function is not fully understood. Here, we report
an in vitro biochemical study that shows that Sco1 is a metallocha-
perone that selectively transfers Cu(I) ions based on loop recogni-
tion, whereas Sco2 is a copper-dependent thiol reductase of the
cysteine ligands in the oxidase. Copper binding to Sco2 is essential
to elicit its redox function and as a guardian of the reduced state
of its own cysteine residues in the oxidizing environment of the
mitochondrial intermembrane space (IMS). These results provide
a detailed molecular mechanism for CuA assembly, suggesting
that copper and redox homeostasis are intimately linked in the
mitochondrion.
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Copper is an essential transition metal in cells, where it bindsto biomolecules with high affinity and plays a myriad of
catalytic and signaling roles, all of them stemming from its redox
capabilities. At the same time, these features make free copper
ions toxic by outcompeting other metal ions in binding the target
metalloproteins and as a source of reactive oxygen species (1).
Living organisms thus resort to different strategies aimed to
transport copper ions and regulate their levels in the cell, such as
the use of metallochaperones, which bind copper ions and deliver
them specifically to the target proteins (2–6).
Copper is an essential cofactor of cytochrome c oxidase (COX),
the terminal oxidase of the respiratory chain in most organisms.
COX I and COX II are the two copper-containing subunits harboring
the CuB and CuA sites, respectively, conserved in heme-copper
oxidases (7–9). Assembly of the oxidase is a complex process
involving the synthesis and folding of the individual subunits and
the incorporation of the metal cofactors (10). For the human
oxidase, at least seven genes encoding for different proteins are
required for maturation of these two copper sites (11–17).
CuA is a binuclear copper center that provides the electron
entry port of the oxidase in subunit II, located in the inter-
membrane space (IMS) of mitochondria or in the bacterial
periplasm (18). Proteins Cox17, Sco1, and Sco2 are involved in
the assembly of the CuA site in eukaryotes. All these proteins
(including COX II) bind copper through two Cys ligands whose
redox status is tightly linked to their function (19, 20). Cox17 is a
soluble metallochaperone that transfers Cu(I) ions to both Sco1
and Sco2 (21, 22). Sco1 and Sco2 are homologous proteins,
anchored to the inner mitochondrial membrane through a single
transmembrane helix that locates their soluble, copper-binding
domain in the IMS (15, 23). Both proteins share a thioredoxin
fold and bind copper ions through a functional CX3C motif
complemented by a histidine residue located in a β-hairpin absent
in thioredoxins (24–27). This CX3CXnH motif allows Sco pro-
teins either to bind Cu(I) with high affinity or to act as thiol-
oxidoreductases (27–29). Both Sco1 and Sco2 are essential for
CuA biogenesis in humans, but their specific roles are unknown,
and a detailed mechanism for CuA assembly in mammalian ox-
idases is still lacking. The fact that metal site assembly requires
the involvement of two orthologous, essential proteins, remains
puzzling. So far, the lack of a soluble variant of human COX II
has precluded a biochemical study of the function of these proteins.
Here, we report the design of a chimeric COX II variant that
enables a biochemical and biophysical study. Based on these
experiments, we posit a mechanism of assembly of the CuA site in
human COX II that allows us to propose specific, complemen-
tary roles for Sco1 and Sco2. We show that (i) Sco1 is the
metallochaperone that delivers the two Cu(I) equivalents to
COX II; (ii) Sco1 and COX II have evolved specific protein–
protein recognition based on the sequences of the loops containing
the copper ligands; and (iii) Sco2 is responsible of reducing the Cys
residues of COX II, but it performs this redox function in its Cu
(I)-bound form rather than through a simple disulfide exchange
reaction as observed in bacteria. This model reveals the versa-
tility of the Sco scaffold in fulfilling different copper-dependent
functions and, at the same time, providing high selectivity in the
metal homeostasis network.
Significance
Cellular respiration in humans depends on the correct assembly
of a copper site (CuA) in cytochrome oxidases. Because copper is
toxic at high levels, cells require specific mechanisms to regu-
late copper transport and delivery. Two proteins from the Sco
family are involved in this mechanism in human mitochondria,
and mutations on any of these proteins jeopardize the assem-
bly of the CuA site, leading to lethal pathologies in newborns.
We show that Sco1 is a protein responsible for delivering the
copper ions to the oxidase, with a high degree of selectivity.
Sco2, instead, provides electrons to reduce the nonmetallated
site of the oxidase. This evidence allow us to propose a mech-
anism for assembly of the CuA site in eukaryotes.
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Engineering a Soluble Human COX II. COX IIs from different or-
ganisms present a characteristic copper-binding site defined by
loops protruding from a conserved β-barrel fold (known as the
cupredoxin fold) anchored to the membrane by one or two long
N-terminal transmembrane helices (Fig. 1 and Fig. S1). Removal
of this transmembrane stretch has allowed the expression of
soluble COX II domains from several bacterial oxidases (30, 31).
Among them, the soluble fragment from Thermus thermophilus
COX II (Tt COX II hereafter) is the only one stable for long
periods of time and under different conditions (32, 33). Instead,
no eukaryotic COX II subunit has been expressed in a stable,
soluble form to date. This may be due to the fact that COX II
from eukaryotic oxidases displays many hydrophobic interactions
with neighboring subunits, whereas the smaller bacterial proteins
contain a periplasmic COX II subunit with no additional in-
teractions (Fig. S1). We attempted expression of the human
COX II (containing only the cupredoxin domain), but we were
unable to obtain a soluble and properly folded protein. Different
constructs were considered: (i) replacing hydrophobic residues in
the protein surface by polar residues to improve the solubility,
(ii) removing different insertions present in the eukaryotic oxi-
dases that allow interaction with other COX subunits, and (iii)
different truncation levels. None of these constructs provided a
soluble human COX II variant to allow in vitro biochemical
studies. We then resorted to a different strategy.
The metal-binding region of COX II comprises a long loop
containing five of the six CuA ligands in a conserved CX(E/
Q/W)XCX3HX2M motif (Fig. 1) (34). We have proposed that this
region, together with two other neighboring loops, could be in-
volved in the interaction with the metallochaperone (33). Based
on this hypothesis, we have designed a chimeric protein by grafting
the three loops of the human protein into the stable scaffold of the
Thermus protein (Fig. 1). The chimeric protein (COX II* here-
after) binds two copper ions and, in its oxidized form, displays the
typical spectroscopic signatures of mixed-valence CuA sites (35).
The heteronuclear single-quantum correlation (HSQC) spectra of
15N apo-COX II*2SH (where 2SH indicates that the Cys ligands
are in the reduced state) show upon copper(I) titration (i)
chemical shift perturbations of resonances corresponding to
residues close to the metal-binding region, and (ii) the appear-
ance of several cross peaks corresponding to residues in the
engineered loops (Fig. S2) that were not observed in the spec-
trum of the metal-free protein, most likely broadened because of
conformational exchange processes occurring in the intermedi-
ate regime (33). These differences in the NMR spectra of apo and
di-Cu(I) forms of COX II* can be exploited to follow copper
uptake from the potential protein donors. Furthermore, the oxi-
dation state of the cysteine thiols in apo-COX II* can also be
monitored through the HSQC spectra, as revealed by chemical
shift changes and signal broadening in the reduced form (apo-
COX II*2SH) with respect to the oxidized one (apo-COX II*S-S)
(Fig. S3). We can thus use NMR spectroscopy to follow the two
essential events required for formation of the CuA site, namely
reduction of the oxidized cysteines and metal binding. In addi-
tion, we conclude that the chimeric soluble protein is a good
model to study the interactions with the putative human copper
chaperones Sco1 and Sco2 and to unravel their role in copper
incorporation into COX II.
Sco1 Is a Specific Copper Chaperone for Human COX II. When 15N
apo-COX II*2SH was reacted with two equivalents of unlabeled
human Cu(I)-Sco1, we observed formation of the colorless di-Cu
(I) adduct, identical, based on an NMR spectrum, to that ob-
tained by addition of free Cu(I) in solution (Fig. 2A and Fig. S2).
Copper transfer was complete at a 2:1 stoichiometry. Human
Cu(I)-Sco1, instead, was unable to effectively transfer Cu(I) ions
to Tt COX II: cross peaks corresponding to a species different
from the apo or the di-Cu(I) form were detected (Fig. S4), sug-
gesting that the process is arrested in a nonproductive form.
Similarly, no metal transfer to form a native CuA site was ob-
served when Cu(I)-TtSco1 was added to apo-COX II*2SH (Fig.
S5). These results reveal that the engineered loops in COX II*
play a role in specific protein–protein recognition by human Sco1
and in Cu(I) transfer. This selectivity validates the use of this
chimera as a model for the human protein, and provides evidence
on the role of the loops in COX II in this process.
Addition of human Cu(I)-Sco2 to apo-COX II*2SH, instead,
led to formation of only 30% of the di-Cu(I) adduct *. This re-
action did not proceed further even upon addition of excess
Cu(I)-Sco2. Furthermore, resonances corresponding to a species
similar to that observed for the nonproductive transfer between
human Cu(I)-Sco1 and the bacterial COX II domain (Fig. S6)
appeared. The formation of this adduct suggests that this path-
way is not efficient enough for copper transfer. We conclude that
(i) human Sco1 is able to produce a fully metallated COX II,
(ii) metallation by human Sco2 is not efficient, and (iii) Cu(I)
insertion by Sco1 is facilitated by protein–protein recognition
involving the engineered loops (Fig. 2B).
Copper-Bound Human Sco2 Is a Thiol Oxidoreductase of the Cys
Residues in COX II. The IMS of mitochondria is an oxidizing en-
vironment, with a redox potential of −255 mV (36). The re-
duction potential of the Cys residues in apo-COX II* is −288 ±
3 mV, identical to that of apo Tt COX II (Fig. S7). Thus, the apo
form of a newly synthesized COX II is expected to have the two
Cys ligands at least partially oxidized, being therefore unable to
bind the Cu(I) ions. Sco proteins have been suggested to act as
thiol reductases of the Cys ligands of COX II based on their
thioredoxin fold (27, 37), which is indeed supported by in vitro
experiments on the bacterial thermophilic Sco protein (32, 37).
Based on the reduction potentials of the S-S/2SH redox couple
of the human proteins: Cox17 (−198 mV) > Sco1 (−277 mV) >
COX II* (−288 mV) > Sco2 (less than −300 mV) (24, 38, 39),
Sco2 would be the only protein able to reduce the disulfide bond
in COX II*. We tested the redox reactivity of either human Sco1
Fig. 1. Design of the chimeric COX II* protein. (A) Comparison of the
structures of the soluble COX II domains from Thermus thermophilus ba3
oxidase [Protein Data Bank (PDB) ID code 2CUA; green] and human cyto-
chrome c oxidase (red). The latter was modeled based on the structure of the
bovine oxidase (PDB ID code 1V54) (46). (B) Model of the chimeric COX II*
colored in green in the region coming from the Thermus oxidase and in red
in the loops taken from the human protein. (C) Sequence alignment of the
loops corresponding to the COX II subunits from Thermus thermophilus (Tt),
bovine (Bt), human (Hs), and the chimeric COX II*.
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Fig. 2. Human Sco1 specifically recognizes the loops of human COX II to assemble its CuA site. (A)
15N, 1H HSQC spectrum of Apo-COX II*2SH (green) and upon
addition of two equivalents of Cu(I)-Sco1 (red), showing complete copper transfer. (B) Summary of the copper transfer experiments (spectra shown in
Supporting Information). The green arrow indicates the stoichiometric transfer of two Cu(I) ions from Sco1 to COX II*, and the red lines indicate unsuccessful
Cu(I) transfer assays.













or human Sco2 in their apo, reduced state with oxidized apo-
COX II*S-S. The reactions were followed by SDS/PAGE under
nonreducing conditions followed by treatment with 4-acetamido-
4′-maleimidylstilbene-2,2′-disulfonic acid, disodium salt (AMS),
a reagent that adds 0.5 kDa per each free thiol group. Incubation
of oxidized apo-COX II*S-S with apo-Sco12SH did not elicit any
reduction, consistent with the redox potentials of these proteins.
Instead, treatment with Sco2 led to formation of reduced apo-
COX II*2SH, but the reaction was not complete (Fig. 3A).
Biochemical studies have shown that both Sco1 and Sco2 in
human mitochondria are present in a mixture of two forms, one
of which was reactive with AMS (19). The presence of a Sco1
form with free thiols in the mitochondria is consistent with its
redox potential, but Sco2 is expected to be fully oxidized in the
IMS. The AMS-reactive form of Sco2 could, however, corre-
spond either to reduced Sco2, or to a copper-bound form, be-
cause copper is dissociated in the gel assays. We therefore tested
the reactivity of oxidized apo-COX II*S-S with Cu(I)-Sco1 and
Cu(I)-Sco2, finding that Cu(I)-Sco2 was able to completely re-
duce the thiol groups of apo-COX II*S-S (Fig. 3B). This reaction
was complete at a 2:1 stoichiometry, indicating that Cu(I)-Sco2
provides one reducing equivalent per molecule. Cu(I) Sco1, in-
stead, did not show any reactivity even at a 2:1 stoichiometric
ratio (Fig. S8). Thus, Sco2 is able to act as an efficient disulfide
reductase of COX II only in its copper-loaded form.
Leary et al. (19) have shown that overexpression of Sco2 in
Sco2 cells alters the ratio of oxidized versus reduced Cys of Sco1
in the mitochondria, suggesting a redox interplay between the
two Sco proteins. We reacted Sco2S-S with apo-Sco12SH and with
Cu(I)-Sco1, and the reaction samples were treated with iodoa-
cetamide (IAM), and studied by MS. No redox reaction was
observed in any of these cases (Fig. S9), allowing us to conclude
that a direct redox event between the two Sco proteins is not
feasible.
Interplay of Sco Proteins in the Maturation of COX II. The present
results show that (i) only Sco1 is able to deliver the full copper
cargo to human COX II with high specificity, and (ii) Cu(I)-Sco2
is able to provide electrons to reduce the Cys ligands at the CuA
site. The interplay of both human Sco proteins in the whole re-
dox and copper insertion process was followed by NMR spec-
troscopy monitoring the HSQC spectra of COX II*. Addition of
two equivalents of Cu(I)-Sco1 to 15N apo-COX II*S-S did not
elicit any change in its HSQC spectrum, confirming that neither
electron nor copper transfer is viable under these conditions.
When one equivalent of Cu(I)-Sco2 was added to this mixture,
formation of the di-Cu(I)-COX II* form to 50–60% was ob-
served. When Cu(I)-Sco2 was added to oxidized apo-COX II*S-S,
spectral changes indicated full reduction to the apo2SH-COX II*
form, in agreement with the gel experiments (Fig. S10). There
was no evidence of copper transfer in this reaction, confirming
the specificity of Sco1 in the metallation event and the selective
redox function of Cu(I)-Sco2.
Discussion
A series of elegant studies in native and defective human fi-
broblast cell lines by Leary, Shoubridge, and coworkers (15, 19)
have shown that Sco1 and Sco2 play distinct, complementary
roles in the maturation process of the CuA site of human COX
II. Our experiments allow assessing these roles, therefore pro-
viding a mechanism for CuA maturation in eukaryotic COX II.
On one hand, only Sco1 is able to efficiently transfer two Cu(I)
equivalents, whereas it is unable to reduce the cysteines neither
in the apo- nor in the Cu(I)-loaded form. Metal transfer strictly
depends on loop recognition between Sco1 and COX II, which is
organism dependent (Fig. 2B). This selectivity confirms that
these loops are indeed crucial for recognition in the copper
transfer event (33). On the other hand, Cu(I)-Sco2 shows im-
paired metal transfer ability but is able to reduce the cysteines of
apo-COX II*S-S at a 2:1 stoichiometry. The essential require-
ment of two Sco proteins in humans is therefore accounted for
by these different, specific functions. Notably, both human Sco
proteins are active in their copper-bound forms, accounting for
the observation that mutation of any of the copper ligands se-
verely affects the oxidase activity and cellular respiration (40,
41). The most frequent pathological mutations (P174L in Sco1
and E140K in Sco2) are located close to the CX3CXnH motif,
and thus expected to alter either the copper-binding or the redox
capabilities of these proteins. This has been shown to be the case
for mutation P174L in Sco1 (39). The mechanism emerging from
this work shows that the same requirements hold for Sco2.
Studies aimed to address the specific impact of these mutations
on the metal site assembly are required.
The copper-dependent reductase function of Sco2 resembles
the disulfide reductase activity of Cox 17 toward Sco1 in its Cu
(I)-bound form, which, in the latter case, is coupled with copper
transfer (22). Likewise, copper binding to Sco proteins in mito-
chondria is essential for their function not only as metallo-
chaperones, but also to elicit electron transfer to assist its own
delivery to the oxidase. We propose that this aspect has been
exploited by evolution to cope with copper toxicity during copper
delivery. In the specific case of Sco2, Cu(I) binding not only
allows a reaction that does not proceed to completion despite
being thermodynamically favored but (most important) also
prevents oxidation of its own thiol groups in the IMS. The in-
volvement of thioredoxins in the copper homeostasis network is
intimately linked to the onset of metal-binding abilities along the
evolution of the thioredoxin fold, still maintaining its redox
features. In fact, thioredoxins are not able to bind metal ions due
to the presence of a cis-Pro residue, and Sco proteins not only
lack this residue but also feature an additional β-hairpin pro-
viding a His ligand (42), resulting in a neat gain-of-function.
Our experiments show that Sco2 is not able to directly oxidize
Sco1. The fact that this reaction occurs in the mitochondria
strongly suggests that there are other cofactors mediating this
process. One possible candidate for this role is protein COA6,
recently identified as an essential cofactor for oxidase assembly
Fig. 3. Electron transfer reaction followed by AMS-reacted, nonreducing SDS/PAGE. (A) Sco12SH and Sco22SH mixed with COX II*S-S and (B) Cu(I)-bound forms
of the Sco proteins mixed with COX II*S-S. All mixtures were done in a 1:1 ratio, except when indicated. The proteins in their different states are also reported
as reference. Signs + and – indicate if the AMS reactive was added to the mixture. Yellow and red arrows indicate where oxidized and reduced COX II* show
up, respectively, upon addition of AMS to the mixture.
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containing a Cys-rich motif, which was proposed to interact with
COX II and Sco2 (43, 44).
Analysis of the present in vitro data together with previous
evidence (22) support the hypothesis that mitochondrial redox
reactions involving copper make extensive use of Cys-rich motifs
in their copper-bound form. On one hand, copper acts as a guardian
of the thiol groups in the different proteins, preventing oxidation.
On the other hand, this allows mitochondrial Sco proteins to reg-
ulate copper levels at the IMS, as recently shown (45). Thus, the
mechanism herein proposed supports at the molecular level the
emerging view that copper and redox homeostasis are entangled
and possibly coupled in the mitochondrion.
The chimeric COX II* protein herein designed is of great
utility for further in vitro studies. First, it allows pursuing structural
studies to assess the effect of the specific defects associated with
the different pathogenic SCO alleles, and address the molecular
basis of lethal genetic diseases. In addition, the system can be
exploited to assess the role of other COX assembly factors to
further enrich the understanding of the maturation process of
mitochondrial oxidases.
Methods
COX II Clone and Protein Production. The synthetic gene coding for COX II*
was purchased from Genescript, cloned in a pUC57 vector, and subcloned to
the isopropyl β-D-1-thiogalactopyranoside–inducible vector pET9a. Human
Sco1, human Sco2, and Tt Sco1 were expressed in Escherichia coli BL21-Gold
(DE3) cells (Stratagene) to high levels in LB medium. The purification of each
protein in its apo form was done as described (24, 26, 32). COX II* and Tt
COX II were expressed in E. coli Bl21-Gold (DE3) cells (Stratagene). For uni-
formly labeled samples, cultures were grown in 15N/13C-enriched media as
required. The proteins were purified from cell lysates as described elsewhere.
Redox Potential Determination. The reduction potential of the Cys residues in
apo-COX II* was estimated from the changes in emission fluorescence at
334 nm during a titration with glutathione. The redox equilibrium was moni-
tored on 5 μM protein samples previously incubated overnight under N2
atmosphere, with different glutathione (GSH)/glutathione disulfide (GSSG)
ratios (0.1 mMGSSG and varying concentrations of GSH, 10–200 mM) in 50 mM
phosphate buffer, pH 7. Data collection and analysis were performed following
the protocol described for human Sco1 (39).
NMR Spectroscopy. NMR experiments were carried out on a 600-MHz Bruker
Avance II spectrometer equipped with a triple resonance inverse (TXI) probe,
a 900-MHz Bruker Avance II spectrometer equipped with a triple resonance
inverse (TCI) cryoprobe, and a 950-MHz Bruker Avance III spectrometer
equipped with a CP TCI CryoProbe. All experiments were carried out at 298 K
using standard techniques.
Backbone resonance assignments for holo-COX II* were obtained by
analyzing HSQC, HNCO, HN(CA)CO, HNCA, HN(CO)CA, CBCA(CO)NH, and
HNCACB experiments acquired on a uniformly labeled 13C and 15N sample
prepared in 100 mM potassium chloride and 100 mM potassium phosphate
buffer at pH 6. Because all subsequent titrations were performed at pH 7,
the backbone 15N and 1H assignments were transferred from pH 6 to 7 by
following the position of the N, H cross peaks in HSQC spectra of a pH
titration.
Protein–protein titrations were performed in anaerobic conditions using
0.2–1.5 mM protein samples prepared in 50 mM potassium phosphate buffer
at pH 7 and followed by NMR spectroscopy. Samples of proteins with their
cysteine thiols in the reduced state were obtained by addition of 10 mM DTT
for 30 min followed by removal of the reducing agent through desalting in
an anaerobic chamber. Cu(I)-bound forms of Sco proteins were obtained by
addition of two equivalents of Cu(I) to the reduced samples followed by
removal of excess Cu(I) through desalting in anaerobic chamber.
AMS-reacted gels to probe redox state of cysteines. The redox state of the cys-
teine residues in protein mixtures was investigated by nonreducing SDS/
PAGE, after reaction of the samples with AMS, a reagent that alkylates free
thiols adding a Mr of ∼0. 5 kDa for each reduced cysteine. Reduced and
oxidized samples and protein mixtures were (20–40 μM) treated in an an-
aerobic environment with 1% (wt/vol) SDS and 10 mM AMS for 1 h at 37 °C,
and resolved by 17% nonreducing SDS/PAGE.
MALDI-TOF experiments. The 20 μM samples of reference samples and mixtures
of Sco1 and Sco2 in different oxidation states were derivatized by addition
of 20 mM IAM, followed by 1-h incubation at room temperature in an an-
aerobic chamber. To remove excess nonreacted IAM, the protein samples
were precipitated using 80% acetone and the protein pellets were re-
suspended in 20 mM phosphate solution at pH 7. Protein adducts were
identified by MALDI-TOF MS in a Bruker Daltonics Ultraflex III TOF/TOF
instrument.
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